-
Clinithink’s CLiX natural language processing solution plays a key role in achieving a GUINNESS WORLD RECORDS™ title for fastest genetic diagnosis
Mar 8, 2018, 11:48 AM by Michael CroftLONDON, UNITED KINGDOM - Mar 8, 2018 - Clinithink has helped to achieve a GUINNESS WORLD RECORDS title for the Fastest genetic diagnosisFull story -
WuXi NextCODE Announces Genomics Partnership with Google Cloud
Mar 7, 2018, 12:00 PM by Michael CroftBio-IT World | WuXi NextCODE today announced a partnership with Google Cloud. WuXi NextCODE’s core suite of capabilities—including GORdb, WuXi NextCODE secondary analysis, the Sequence Miner case-control research application, and the Clinical Sequence Analyzer clinical interpretation system—will be hosted on Google Cloud and available on the Google Cloud Launcher marketplace.Full story -
2bPrecise and The Innovation Institute to Deliver Robust Pharmacogenomics Platform, GeneFolio, to the Point of Care
Mar 7, 2018, 11:22 AM by Michael CroftNEWTON, MA, UNITED STATES - Mar 7, 2018 - HIMSS 2018 - LAS VEGAS - March 7, 2018 - 2bPrecise®, LLC, and The Innovation Institute announced today that they have entered into an agreement that lays the foundation for 2bPrecise to deliver a pharmacogenomics knowledge base to the point of care for The Innovation Institute's network of member providers, as well as others beyond the networkFull story -
Medherant expands team with appointment of David Davies as Head of Development
Mar 7, 2018, 05:30 AM by Michael CroftCOVENTRY, UK - Mar 7, 2018 - Medherant Ltd, a leader in next-generation transdermal drug delivery, is pleased to announce the appointment of a new senior executive, David Davies, as Head of DevelopmentFull story -
BC Platforms Launches an End-to-End Solution for Precision Medicine powered by the Microsoft Genomics Service
Mar 7, 2018, 03:27 AM by Michael CroftBOSTON, MA - Mar 7, 2018 - BC Platforms, a pioneer in genomic data management and analytics, today announces it has launched GeneVision, a new end-to-end Solution for Precision Medicine, that uses the Microsoft Genomics service which runs on Microsoft AzureFull story -
FDA Authorizes 23andMe BRCA Consumer Test
Mar 6, 2018, 12:50 PM by Michael CroftBio-IT World News Brief | FDA today authorized a direct-to-consumer genetic test for cancer risk. The authorization allows 23andMe to provide customers, without a prescription, information on three genetic variants found on the BRCA1 and BRCA2 genes known to be associated with higher risk for breast, ovarian, and prostate cancer.Full story -
Shivom Partnership With Genetic Technologies Will Enable Better Cancer Prediction and Prevention Through Mass Genomic Data Analysis
Mar 6, 2018, 09:37 AM by Michael CroftMELBOURNE, AUSTRALIA - Mar 6, 2018 - Shivom, the blockchain-powered global Unique ID genomic database platform, has today announced a major partnership with leading molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) that is expected to accelerate the prediction of cancer for millions of individuals worldwideFull story -
Gene By Gene Selects BC Platforms to enhance its world leading Genomic data processing services
Mar 6, 2018, 05:43 AM by Michael CroftBOSTON, MA - Mar 6, 2018 - BC Platforms, a world leader in genomic data management and analytics, announces that it has been selected by Gene By Gene, the industry leader in offering integrated multi-disciplinary genetic testing services, to scale up its genomic data processing and storage capabilitiesFull story -
Ballot is Open For 2018 Benjamin Franklin Award Winner
Mar 5, 2018, 13:50 PM by Michael CroftBio-IT World Bioinformatics.org has announced five finalists for the 2018 Benjamin Franklin Award for Open Access in the Life Sciences, including the first finalist team. Voting will be open until Monday, March 12. Finalists are Christine Durinx, SIB Swiss Institute of Bioinformatics & Johanna McEntyre, EMBL-EBI; Melissa Haendel, Oregon Health and Science University; Desmond Higgins, University College Dublin (UCD) Conway Institute; B.F. Francis Ouellette, Ontario Institute of Cancer Research; and Frank W. Rockhold, Duke University Medical Center.Full story -
The Latest in Data Integration and Personalized Medicine: Updates from the 2018 Molecular Medicine Tri-Conference
Mar 5, 2018, 12:30 PM by Michael CroftFull storyBio-IT World In San Francisco last month, Bio-IT World caught up with leaders in data management and cloud computing at Tri-Con’s Converged IT & the Cloud track. In a series of talks and panel discussions, they shared their experiences dealing with the challenges of storing, transferring and integrating vast amounts of data from a broad range of sources.
-
The Man Who Uncovered a New (Old) Way to Fight Cancer
Mar 5, 2018, 10:39 AM by Michael CroftMIT Technology Review | Matthew Vander Heiden helped revive the forgotten- but critical-study of cancer metabolism.Full story -
MDI Biological Laboratory Launches New Course on Organoid Technology
Mar 5, 2018, 09:46 AM by Michael CroftBAR HARBOR, ME, UNITED STATES - Mar 5, 2018 - The MDI Biological Laboratory in Bar Harbor, Maine, has announced that it will offer a one-week intensive course May 27 through June 2, 2018 entitled Applications of Organoid Technology in partnership with Hubrecht Organoid Technology (The HUB), a non-profit organization based in Utrecht, NetherlandsFull story -
BioIVT Launches New Website, Highlighting Expanded Biospecimen Product and Service Portfolios for Drug Development Researchers
Mar 5, 2018, 08:12 AM by Michael CroftWESTBURY, NY - Mar 5, 2018 - BioIVT, a leading provider of biospecimens and related services, today announced the launch of its comprehensive, new, user-friendly website at wwwFull story -
NIH, Inova Launch 10K-Person Database For Re-Contact
Mar 1, 2018, 11:45 AM by Michael CroftBio-IT World News Brief | The National Institutes of Health and Inova Health System today announced The Genomic Ascertainment Cohort (TGAC), a two-year pilot project that will allow researchers to re-contact genotyped people and examine the genes and gene variants' influence on their phenotypes, an individual's observable traits, such as height, eye color or blood type.Full story -
Saneca Pharma renews Pharmascience agreement following successful quality audit
Mar 1, 2018, 10:51 AM by Michael CroftHLOHOVEC, SLOVAKIA - Mar 1, 2018 - Contract development and manufacturing organisation (CDMO) Saneca Pharma has renewed an agreement with Pharmascience Inc, one of Canadas largest pharmaceutical companies, for the manufacture and supply of prescription medicines in tablet formFull story -
23andMe Adds 120 New Regions To Its Ancestry Test
Feb 28, 2018, 14:49 PM by Michael CroftCNBC | At-home DNA testing company 23andMe is including 120 new regions in its ancestry report, making the test far more specific in its results.Full story -
Riffyn Awarded Its First US Patent for Experiment Design and Data Analytics
Feb 28, 2018, 09:58 AM by Michael CroftOAKLAND, CA, US - Feb 27, 2018 - Riffyn, a provider of cloud-based R&D software, announced that the United States Patent Office has granted its patent on a hypergraph data model for experiment design and data analysis (UFull story -
Dovetail Genomics, Illumina, The Broad Institute, And More: News From February 2018
Feb 28, 2018, 09:25 AM by Michael CroftFull storyBio-IT World | February featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Dovetail Genomics, Illumina, The Broad Institute, and more.
-
Equus Compute Solutions Launches Servers with New Intel® Xeon® Scalable CPUs
Feb 27, 2018, 11:41 AM by Michael CroftEDINA, MN, UNITED STATES - Feb 27, 2018 - Equus Compute Solutions announced today the availability of servers that use the new Intel® Xeon® Processor Scalable Family (aka Purley)Full story -
Certara Demonstrates Proof of Concept for its Virtual Twin™ Technology
Feb 27, 2018, 08:54 AM by Michael CroftPRINCETON, NJ - Feb 27, 2018 - Certara®, the global leader in model-informed drug development and regulatory science, today announced that it has published two papers demonstrating proof of concept for its Virtual Twin technologyFull story